Search research articles
Contact Us
Filters
Showing results (11-20 of 90) with videos related to
Page
of 9
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology
|
January 1, 2005
PGE2-induced hypertrophy of cardiac myocytes involves EP4 receptor-dependent activation of p42/44 MAPK and EGFR transactivation
Mariela Mendez, Margot C LaPointe
Hypertension (Dallas, Tex. : 1979)
|
January 21, 2000
Role of Ca(2+)-independent phospholipase A(2) in the regulation of inducible nitric oxide synthase in cardiac myocytes
E Isenović, M C LaPointe
Hypertension (Dallas, Tex. : 1979)
|
January 21, 2000
Interleukin-1beta regulates the human brain natriuretic peptide promoter via Ca(2+)-dependent protein kinase pathways
Q He, M C LaPointe
Hypertension (Dallas, Tex. : 1979)
|
February 4, 1999
Interleukin-1beta regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes
Q He, M C LaPointe
Hypertension (Dallas, Tex. : 1979)
|
March 7, 2001
Src and Rac mediate endothelin-1 and lysophosphatidic acid stimulation of the human brain natriuretic peptide promoter
Q He, M C LaPointe
L' Infirmiere Canadienne
|
October 1, 1979
[Cesarean section]
J Céré, C Lapointe-Landry
Hypertension (Dallas, Tex. : 1979)
|
February 4, 1999
Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes
M C LaPointe, E Isenović
Hypertension (Dallas, Tex. : 1979)
|
March 8, 2002
Trophic effects of the cyclooxygenase-2 product prostaglandin E(2) in cardiac myocytes
Mariela Mendez, Margot C LaPointe
Revue D'Epidemiologie Et De Sante Publique
|
January 1, 1990
[Calculation of sample size for the detection of relative risk with a predetermined confidence level and power]
P M Bernard, C Lapointe
Hypertension (Dallas, Tex. : 1979)
|
March 1, 1996
Mechanisms of interleukin-1beta regulation of nitric oxide synthase in cardiac myocytes
M C LaPointe, J R Sitkins
Page
of 9
Search research articles
Search
Showing results (11-20 of 90) with videos related to
Sort By:
Page
of 9
American Journal of Physiology. Heart and Circulatory Physiology
|
January 1, 2005
PGE2-induced hypertrophy of cardiac myocytes involves EP4 receptor-dependent activation of p42/44 MAPK and EGFR transactivation
Mariela Mendez, Margot C LaPointe
Hypertension (Dallas, Tex. : 1979)
|
January 21, 2000
Role of Ca(2+)-independent phospholipase A(2) in the regulation of inducible nitric oxide synthase in cardiac myocytes
E Isenović, M C LaPointe
Hypertension (Dallas, Tex. : 1979)
|
January 21, 2000
Interleukin-1beta regulates the human brain natriuretic peptide promoter via Ca(2+)-dependent protein kinase pathways
Q He, M C LaPointe
Hypertension (Dallas, Tex. : 1979)
|
February 4, 1999
Interleukin-1beta regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes
Q He, M C LaPointe
Hypertension (Dallas, Tex. : 1979)
|
March 7, 2001
Src and Rac mediate endothelin-1 and lysophosphatidic acid stimulation of the human brain natriuretic peptide promoter
Q He, M C LaPointe
L' Infirmiere Canadienne
|
October 1, 1979
[Cesarean section]
J Céré, C Lapointe-Landry
Hypertension (Dallas, Tex. : 1979)
|
February 4, 1999
Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes
M C LaPointe, E Isenović
Hypertension (Dallas, Tex. : 1979)
|
March 8, 2002
Trophic effects of the cyclooxygenase-2 product prostaglandin E(2) in cardiac myocytes
Mariela Mendez, Margot C LaPointe
Revue D'Epidemiologie Et De Sante Publique
|
January 1, 1990
[Calculation of sample size for the detection of relative risk with a predetermined confidence level and power]
P M Bernard, C Lapointe
Hypertension (Dallas, Tex. : 1979)
|
March 1, 1996
Mechanisms of interleukin-1beta regulation of nitric oxide synthase in cardiac myocytes
M C LaPointe, J R Sitkins
Page
of 9